Histone demethylase Jumonji domain‐containing 1A inhibits proliferation and progression of gastric cancer by upregulating runt‐related transcription factor 3

Ke Ning,Yangguang Shao,Yuxin He,Fei Wang,Xi Cui,Furong Liu,Danni Li,Feng Li
DOI: https://doi.org/10.1111/cas.14594
IF: 5.7
2020-09-06
Cancer Science
Abstract:<p>The histone demethylase JMJD1A(Jumoji domain containing 1A) is overexpressed in multiple cancers and promotes cancer progression. However, the role and mechanism of JMJD1A in gastric cancer (GC) remains poorly understood. Here, we found that JMJD1A could suppress GC cell proliferation and xenograft tumor growth. Using RNA sequencing, we identified RUNX3 as a novel target gene of JMJD1A. Mechanistically, we identified that JMJD1A up‐regulated RUNX3 through co‐activating Ets‐1 and reducing the H3K9me1/2 levels at the RUNX3 promoter in GC cells. Functionally, JMJD1A inhibits the growth of GC cells <i>in vivo </i> dependent on RUNX3 partially. Moreover, JMJD1A expression was decreased in GC and low expression of JMJD1A was correlated to an aggressive phenotype and a poor prognosis in patients with GC. Importantly, JMJD1A expression was positively associated with RUNX3 expression in GC samples. These studies indicated that JMJD1A up‐regulates RUNX3 expression via co‐activation of transcription factor Ets‐1 to inhibit proliferation of GC cells. Our findings provide new insights into the mechanism by which JMJD1A regulates <i>RUNX3 </i> transcription and suggest that JMJD1A and/or RUNX3 may be a therapeutic intervention of GC.</p>
oncology
What problem does this paper attempt to address?